Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate
- 14 October 2005
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 16 (12) , 2063-2068
- https://doi.org/10.1007/s00198-005-2001-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- Management of Paget's disease of boneRheumatology, 2004
- Efficacy and safety of ibandronate given by intravenous injection once every 3 monthsBone, 2004
- Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosisBone, 2004
- Oral Daily Ibandronate Prevents Bone Loss in Early Postmenopausal Women Without OsteoporosisJournal of Bone and Mineral Research, 2004
- Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosisExpert Opinion on Pharmacotherapy, 2003
- Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal womenAnnals of the Rheumatic Diseases, 2003
- Bisphosphonates for cancer patients: why, how, and when?Supportive Care in Cancer, 2001
- Ibandronate: A Comparison of Oral Daily Dosing Versus Intermittent Dosing in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2001
- The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding studyBone, 1996